Krishna Medical Institution Ltd (KIMS) was incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. Initially established as Jagjit Singh and Sons Private Limited in 1973 in Mumbai, the company's name was changed to Krishna Institute of Medical Sciences Private Limited in 2004. Upon its conversion to a Public Limited Company, the name was changed to Krishna Institute of Medical Sciences Limited on January 29, 2004.
The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities. KIMS Hospitals is one of the largest corporate healthcare groups in Telangana and AP, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. The Group offers healthcare services in specialties and super specialties across more than 40 fields.
The company operates 12 multi-specialty hospitals under the "KIMS Hospitals" brand, with an aggregate capacity of over 4,000 beds. KIMS manages 12 multispecialty hospitals, providing a wide array of healthcare services across more than 40 specialities and super specialities. These include cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and childcare.
Krishna Institute of Medical Sciences, or KIMS, is a corporate healthcare group, with hospitals in Telangana, Andhra Pradesh and Maharashtra. It provides multi-disciplinary integrated healthcare services with a focus on tertiary and quaternary healthcare. KIMS began its journey in Nellore, Andhra Pradesh, establishing its oldest hospital with a capacity of about 200 beds. Over the years, the group ventured into various cities in Andhra Pradesh and Maharashtra, apart from Telangana.
The company has been pursuing an aggressive expansion strategy in recent years. In 2021, KIMS acquired a stake in Hyderabad-based Sunshine Hospitals. The following year, in 2022, it expanded its footprint by signing an MoU with Dr Raj Nagarkar, a surgical oncologist in western Maharashtra, to establish KIMS Manavata Hospital, a multi-specialty facility in Nashik with a total bed capacity of 325. KIMS also acquired a majority stake in Kingsway Hospitals in Nagpur in 2022.
The company is all set to enter Karnataka in the ensuing year with a 250-bed hospital in the heart of Bengaluru. There are immediate plans to expand its wings to Thane, Mumbai in the next year. All these initiatives will lead to a doubling of its capacity to 8,000 beds in the next 2-3 years spanning across the states of Telangana, AP, Maharashtra and Karnataka.
The company's market capitalization stands at ₹28,530 crore as of recent data, representing a 63.3% increase over the past year. As of March 2025 (Q4 FY25), the company reported revenue of ₹796.90 crore and net profit of ₹106.10 crore.
The company's financial performance has been robust, with consistent growth in revenue and profitability. Krishna Institute of Medical Sciences Ltd's net profit jumped 55.42% since last year same period to ₹101.80 crore in Q4 2024-2025. Net profit of Krishna Institute of Medical Sciences rose 55.42% to Rs 101.80 crore in the quarter ended March 2025 as against Rs 65.50 crore during the previous quarter ended March 2024.
KIMS share price has gained over 70% in the last one year. The 52-week high price of Krishna Institute of Medical Sciences Ltd (KIMS) is Rs 708.00 while the 52-week low price is Rs 350.00. The stock P/E ratio is 75.9.
Compared to the current market price of 673.6 INR, Krishna Institute of Medical Sciences Ltd is Overvalued by 21%. According to Wall Street analysts, the average 1-year price target for KIMS is 714.57 INR with a low forecast of 585.8 INR and a high forecast of 840 INR.
KIMS was listed on the stock exchanges on June 28, 2021. The company is led by Bhaskara Rao Bollineni as the Chairperson. The promoter holding stands at 38.8%.
Its technologies include 4-Arm HD da Vinci Robotic Surgical System, O-Arm Scanner, Novalis Tx Linear Accelerator, 3 Tesla MRI, EBUS, Spy Glass, Mako Robotic for Knee Replacement, and Impella. The Company's institutes include the institute of Cardiac Sciences, Institute of Dental Science, Institute of Gastroenterology & Hepatology, Institute of Heart & Lung Transplantation, and Institute of Neuro Sciences.
The company has demonstrated strong operational performance with consistent growth in patient volumes and revenue per bed. The Sunshine Hospitals which came into the hands of KIMS generated a revenue contribution of 19%. The KIMS SUNSHINE will be shifted soon to the company's premises which will add 300 new beds.
Krishna Institute of Medical Sciences Limited continues to strengthen its position as a leading healthcare provider in South India, with strategic expansion plans and consistent financial performance making it an attractive investment proposition in the healthcare sector.
